KeyGene and University of Minnesota enter into a license agreement on Sequence-Based Genotyping technology
Wageningen, Netherlands and St. Paul, Minnesota, USA
February 24, 2016
KeyGene and University of Minnesota jointly announced today that they have entered into a license agreement which allows UMN to practice KeyGene's proprietary Sequence-Based Genotyping (SBG) technology. With this agreement, the University of Minnesota Genomics Center (UMGC) is enabled for the use and application of KeyGene’s patented SBG technology throughout the UMN System. The SBG technology allows rapid and costeffective discovery and scoring of genetic variation for improvement of crops without prior knowledge of their genomic sequences. By means of this technology genome-wide SNP discovery and genotyping is achieved in a single experiment. KeyGene has established a strong proprietary position on SBG with world-wide IP protection and works collaboratively with industry and academia to enable their research programs through SBG.
"SBG is a transformative technology that is vital for translational agriculture. University of Minnesota is one of the world's best institutions for agricultural sciences and KeyGene is proud to make SBG technology available to UMGC in support of its efforts to foster research, and drive further discoveries in crop, animal and life sciences" said Fayaz Khazi, Ph.D., Chief Executive Officer of KeyGene USA.
According to Kenneth Beckman, Director of the University of Minnesota Genomics Center: “The UMGC is pleased to be able to provide KeyGene’s SBG technology to University of Minnesota researchers, to aid in discoveries in plant breeding, as well as other fields for which genome-wide genotyping plays a key role.”
About KeyGene
The crop innovation company
KeyGene is a privately owned Ag Biotech company with its primary focus on crop innovation. KeyGene’s approach is to enable molecular genetics for the future of global agriculture. KeyGene supports its strategic partners with cutting edge breeding technologies, bioinformatics and plant-based trait platforms, with more than 135 employees worldwide. KeyGene has sites in Wageningen, the Netherlands and in Rockville, USA.
The Sequence-Based Genotyping technology is protected by patents and patent applications owned by Keygene N.V.
Topics
Species
